Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis

In iron-deficient patients with HF with reduced left ventricular ejection fraction, intravenous FCM was associated with significantly reduced risk of hospital admissions for HF and cardiovascular causes, with no apparent effect on mortality.